Follow RSS for latest reports on this topicTransthyretin-Mediated Amyloidosis - Market Research and Reports
Transthyretin (TTR)-mediated amyloidosis (ATTR) is an inherited, progressively debilitating, and fatal disease caused by mutations in the TTR gene. TTR protein is produced primarily in the liver and is normally a carrier for retinol binding protein. Mutations in TTR cause abnormal amyloid proteins to accumulate and damage body organs and tissue, such as the peripheral nerves and heart, resulting in intractable peripheral sensory neuropathy, autonomic neuropathy, and/or cardiomyopathy. ATTR represents a major unmet medical need with significant morbidity and mortality; familial amyloidotic polyneuropathy (FAP) affects approximately 10,000 people worldwide and familial amyloidotic cardiomyopathy (FAC) affects at least 40,000 people worldwide. FAP patients have a life expectancy of five to 15 years from symptom onset, and the only treatment options for early stage disease are liver transplantation and tafamidis (approved in Europe). The mean survival for FAC patients is approximately 2.5 years, and there are no approved therapies. There is a significant need for novel therapeutics to treat patients who have inherited mutations in the TTR gene.
Related Reports:
We found 22 reports that matched your search.
Refine your search, and find more matches, using the form above.
Amyloidosis Global Clinical Trials Review, H2, 2018 [Report Updated: 31-10-2018]
Amyloidosis Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, “Amyloidosis Global Clinical Trials Review, H2, 2018 provides an overview of Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted acro...Read More >>>
Published:
2018-10-31
Published by: Global Data
Prices Starting From:
$2500
Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2018 [Report Updated: 16-10-2018]
Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2018SummaryTransthyretin (ATTR or Prealbumin or TBPA or TTR) - Transthyretin is a transport protein. It transports thyroid hormones in the plasma and cerebrospinal fluid, and also transports retinol (vitamin A) in the plasma. The diseases caused by mutations include amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amy...Read More >>>
Published:
2018-10-16
Published by: Global Markets Direct
Prices Starting From:
$3500
Amyloidosis - Pipeline Review, H2 2018 [Report Updated: 17-07-2018]
Amyloidosis - Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Amyloidosis - Pipeline Review, H2 2018, provides an overview of the Amyloidosis (Metabolic Disorders) pipeline landscape.Abnormal accumulation of amyloid protein in the tissues results in a group of diseases known as amyloidosis. It may affect the shape and functioning o...Read More >>>
Published:
2018-07-17
Published by: Global Markets Direct
Prices Starting From:
$2000
Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2018 [Report Updated: 29-06-2018]
Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2018SummaryGlobalData's clinical trial report, “Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2018 provides an overview of Primary Systemic Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Primary Systemic Amyloidosis. Report includes an overview of trial ...Read More >>>
Published:
2018-06-29
Published by: Global Data
Prices Starting From:
$2500
Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H1 2018 [Report Updated: 17-04-2018]
Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H1 2018SummaryTransthyretin (ATTR or Prealbumin or TBPA or TTR) - Transthyretin is a transport protein. It transports thyroid hormones in the plasma and cerebrospinal fluid, and also transports retinol (vitamin A) in the plasma.The diseases caused by mutations include amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyl...Read More >>>
Published:
2018-04-17
Published by: Global Markets Direct
Prices Starting From:
$3500
Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Pipeline Insight, 2018 [Report Updated: 14-02-2018]
Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Pipeline Insight, 2018” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) development. The report provides detailed coverage of t...Read More >>>
Published:
2018-02-14
Published by: Delve Insight
Prices Starting From:
$1250
Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 [Report Updated: 14-02-2018]
IntroductionDelveInsight's, “Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 report provides comprehensive insights about marketed and Phase III products for Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) . The report includes information o...Read More >>>
Published:
2018-02-14
Published by: Delve Insight
Prices Starting From:
$2000
Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Epidemiology Forecast to 2027 [Report Updated: 14-02-2018]
DelveInsight's Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Markets...Read More >>>
Published:
2018-02-14
Published by: Delve Insight
Prices Starting From:
$3250
Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Market Insight, Epidemiology and Market Forecast - 2027 [Report Updated: 14-02-2018]
DelveInsight's Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Market Insight, Epidemiology and Market Forecast - 2027 report provides a detailed analysis of the Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) epidemiology and market outlook for the 7MM.Markets Covered• United States• EU5 (Germany, France, ...Read More >>>
Published:
2018-02-14
Published by: Delve Insight
Prices Starting From:
$6250
Global and Chinese Amyloidosis Therapeutics Industry, 2017 Market Research Report [Report Updated: 24-12-2017]
The 'Global and Chinese Amyloidosis Therapeutics Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Amyloidosis Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Amyloidosis Therapeutics manufacturers and is a valuable source of guidance and direction for companie...Read More >>>
Published:
2017-12-24
Published by: Prof Research
Prices Starting From:
$3000
Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2017 [Report Updated: 10-10-2017]
Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2017SummaryAccording to the recently published report 'Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2017'; Transthyretin (ATTR or Prealbumin or TBPA or TTR) pipeline Target constitutes close to 15 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the unive...Read More >>>
Published:
2017-10-10
Published by: Global Markets Direct
Prices Starting From:
$3500
Amyloidosis - Pipeline Review, H2 2017 [Report Updated: 18-07-2017]
Amyloidosis - Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Amyloidosis - Pipeline Review, H2 2017, provides an overview of the Amyloidosis (Metabolic Disorders) pipeline landscape.Abnormal accumulation of amyloid protein in the tissues results in a group of diseases known as amyloidosis. It may affect the shape and functioning o...Read More >>>
Published:
2017-07-18
Published by: Global Markets Direct
Prices Starting From:
$2000
Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Pipeline Insight, 2017 [Report Updated: 10-07-2017]
DelveInsight’s, “ Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) -Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs across this Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease). The key objective of the report is to establish the understanding for all the pipeline drugs that ...Read More >>>
Published:
2017-07-10
Published by: Delve Insight
Prices Starting From:
$1250
Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Market Insights, Epidemiology and Market Forecast – 2025 [Report Updated: 10-07-2017]
DelveInsight’s “Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Market Insights, Epidemiology and Market Forecast – 2025” Reports provides an overview of the disease and global market size of the Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) for the 7MM (United States, Germany, France, Italy, Spain and UK...Read More >>>
Published:
2017-07-10
Published by: Delve Insight
Prices Starting From:
$5750
Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Epidemiology Insights to 2025 [Report Updated: 10-07-2017]
DelveInsight “ Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical ...Read More >>>
Published:
2017-07-10
Published by: Delve Insight
Prices Starting From:
$2950
Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Report Updated: 01-07-2017]
DelveInsight’s, Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” report provides comprehensive insights about marketed and Phase III products for the Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease). The report includes information of market...Read More >>>
Published:
2017-07-01
Published by: Delve Insight
Prices Starting From:
$2000
Amyloidosis Global Clinical Trials Review, H1, 2017 [Report Updated: 31-03-2017]
Amyloidosis Global Clinical Trials Review, H1, 2017SummaryGlobalData's clinical trial report, “Amyloidosis Global Clinical Trials Review, H1, 2017 provides an overview of Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted acro...Read More >>>
Published:
2017-03-31
Published by: Global Data
Prices Starting From:
$2500
Amyloidosis - Pipeline Review, H1 2017 [Report Updated: 28-02-2017]
Amyloidosis - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Amyloidosis - Pipeline Review, H1 2017, provides an overview of the Amyloidosis (Metabolic Disorders) pipeline landscape.Abnormal accumulation of amyloid protein in the tissues results in a group of diseases known as amyloidosis. It may affect the shape and functioning o...Read More >>>
Published:
2017-02-28
Published by: Global Markets Direct
Prices Starting From:
$2000
Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2016
Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2016SummaryGlobal Markets Direct’s, ‘Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2016’, provides in depth analysis on Transthyretin (ATTR or Prealbumin or TBPA or TTR) targeted pipeline therapeutics. The report provides comprehensive information on the Transthyretin (ATTR or Prealbumin or TBPA...Read More >>>
Published:
2016-10-26
Published by: Global Markets Direct
Prices Starting From:
$3500
Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2016
Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2016 provides an overview of Primary Systemic Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Primary Systemic Amyloidosis. Report includes an overview of trial ...Read More >>>
Published:
2016-06-30
Published by: Global Data
Prices Starting From:
$2500
Amyloidosis Global Clinical Trials Review, H1, 2016
Amyloidosis Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Amyloidosis Global Clinical Trials Review, H1, 2016 provides an overview of Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted acro...Read More >>>
Published:
2016-05-31
Published by: Global Data
Prices Starting From:
$2500
Systemic Amyloidosis Market: By Type (Primary systemic amyloidosis (PSA), Amyloidosis associated with multiple myeloma, Secondary systemic amyloidosis) & By Region-Forecast (2016-2021) [Report Updated: 23-03-2016]
Amyloids are the substance made up of abnormally formed protein in the bone marrow that gets saturated in different tissues or organs of the body. The condition is termed as amyloidosis. Amyloidosis is a clinical disorder caused by extracellular and/or intracellular deposition of insoluble abnormal amyloid fibrils that alter the normal function of tissues. Systemic amyloidosis (AL amyloidosis or j...Read More >>>
Published:
2016-03-23
Published by: Industry ARC
Prices Starting From:
$5250
Additional Searches
You may also like to search separately for: Transthyretin-Mediated Amyloidosis
